Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-15-056412
Filing Date
2015-06-25
Accepted
2015-06-25 17:37:41
Documents
2
Period of Report
2015-06-25

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1553
2 EX-24 DOCUMENT attachment1.htm EX-24 4292
  Complete submission text file 0001209191-15-056412.txt   7335
Mailing Address PFIZER INC ATTN CORPORATE SECRETARY 235 EAST 42ND STREET NEW YORK NY 10017
Business Address
Ausiello Dennis A (Reporting) CIK: 0001381994 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37465 | Film No.: 15952602

Mailing Address 215 FIRST STREET SUITE 440 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 440 CAMBRIDGE MA 02142 617 945 9626
Seres Therapeutics, Inc. (Issuer) CIK: 0001609809 (see all company filings)

EIN.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations